Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
09/2005
09/07/2005EP1246642B1 Use of a vector comprising a nucleic acid coding for an anti-angiogenic factor for treating corneal neovascularization
09/07/2005EP1140016B1 Composition set and kit for use in intraocular surgery
09/07/2005CN1665831A Novel compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules
09/07/2005CN1665829A Nonsteroidal anti-inflammatory substances, compositions and methods for their use
09/07/2005CN1665822A 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/07/2005CN1665821A 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/07/2005CN1665815A Novel tetracyclo-aryl-carbonyl indoles used as therapeutical agents with 5-hydroxy-tryptamine receptor affinity, their preparation process and pharmaceutical compounds containing same
09/07/2005CN1665811A Carbamate-substituted pyrazolopyridines
09/07/2005CN1665809A Azaindoles
09/07/2005CN1665807A Novel physiolgically active substances
09/07/2005CN1665804A 4, 4-disubstituted piperidine derivatives having CCR3 antagonism
09/07/2005CN1665537A Use of CETP inhibitors and optionally HMG COA reductable inhibitors and/or antihypertensive agents
09/07/2005CN1665533A Use of heat shock proteins to enhance efficacy of antibody therapeutics
09/07/2005CN1665514A Drugs for treating or preventing disorders of corneal and/or conjunctival epithelial cells
09/07/2005CN1665513A 1, 3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/07/2005CN1665512A Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases
09/07/2005CN1665508A Use of pyrazolo[4, 3-d]pyrimidines
09/07/2005CN1665503A Utilization of heteroarene carboxamide as dopamine-D3 ligands for the treatment of cns diseases
09/07/2005CN1665499A Drug composition for prevention or inhibition of advance of diabetic complication
09/07/2005CN1663614A 复方氨溴索和头孢菌素类制剂及其应用 Compound ambroxol and cephalosporins preparation and its application
09/07/2005CN1663609A Eye drop for treating conjunctivitis and keratitis
09/07/2005CN1663605A Ear drop for treating chronic tympanitis
09/07/2005CN1663588A Medicine for treating eye vitreous hemorrhage and turbidity and its preparation method
09/07/2005CN1663585A Pharmaceutical composition for resisting herpes simplex virus and its preparing process
09/07/2005CN1217918C Aminocyclohexyl ether compounds and uses thereof
09/07/2005CN1217676C Chinese medicine for treating eye diseases
09/07/2005CN1217661C Choline antagonist sticking preparation
09/07/2005CN1217655C Fibrauretine slow releasing preparation
09/06/2005US6939990 Derivatives of dicarboxylic acid having pharmaceutical properties
09/06/2005US6939989 Side-chain halogenated amino dicarboxylic acid derivatives as medicaments for treating cardiovascular diseases
09/06/2005US6939872 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
09/06/2005US6939568 Hydrated dressing containing metal microbiocide
09/06/2005US6939559 Pharmaceutical composition for application to mucosa
09/06/2005US6939542 Contacting vitreous humor with beta-glucuronidase, matrix metalloproteinase, chondroitinase, chondroitin sulfatase, and/or protein kinase; thimerosal-free
09/01/2005WO2005080573A1 Recombinant viral vectors to promote neuronal cell survival and uses thereof
09/01/2005WO2005080385A1 Indanol derivative
09/01/2005WO2005079809A1 Transparent latanoprost eye drops
09/01/2005WO2002083873A3 Enzymes
09/01/2005US20050192322 Calcium blockers to treat proliferative vitreoretinopathy
09/01/2005US20050192307 Benzimidazolone compounds
09/01/2005US20050192304 Rho-kinase inhibitors
09/01/2005US20050192264 Crystal or crystalline composite; crystal size and distribution of which are determinable and selectable; anti-inflammatory steroid is a 11-substituted-16 alpha ,17 alpha -substituted methylenedioxy steroid (triamcinolone acetonide); treat inflammatory eye conditions
09/01/2005US20050192235 Compositions and methods for treating or preventing diseases of body passageways
09/01/2005US20050192208 Cardiovascular disorders; antiarrhythmia agents; sodium channel moderators ; potassium channel moderators; prevent fibrillation
09/01/2005US20050191747 Recombinant bovine immunodeficiency virus based gene transfer system
09/01/2005US20050191301 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses
09/01/2005CA2557539A1 Indanol derivative
09/01/2005CA2554691A1 Tissue system with undifferentiated stem cells derived from corneal limbus
08/2005
08/31/2005EP1568685A1 Aminoadamantane derivatives as therapeutic agents
08/31/2005EP1568382A1 REMEDY FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND &bgr;-BLOCKER
08/31/2005EP1568359A1 Drug delivery system using subconjunctival depot
08/31/2005EP1567644A2 Tissue specific genes and gene clusters
08/31/2005EP1567183A2 Methods and compositions for treatment of otitis media
08/31/2005EP1567160A2 Method of treatment of myocardial infarction
08/31/2005EP1567154A2 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
08/31/2005EP1567150A1 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics
08/31/2005EP1567148A2 Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment and management of macular degeneration
08/31/2005EP1430057B1 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido 1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo 1,2-a]pyrimidin-5(1h)one derivatives
08/31/2005EP1408929B1 Ophthalmic composition containing n-acetylcysteine for the treatment of dry-eye syndrom
08/31/2005EP1397359B1 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors
08/31/2005EP1390366B1 The citrate salt of 5,8,14,-triazatetracyclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaene
08/31/2005EP1268445B1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
08/31/2005EP1140809B1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
08/31/2005EP0882718B1 Benzimidazole derivatives
08/31/2005CN1662703A Appts. and method for extracting kraft paper pulp and atuomatically defibering
08/31/2005CN1662663A DNA enzyme to inhibit plasminogen activator inhibitor-1
08/31/2005CN1662537A Pyrazolo (1, 5-a) pyrimidine derivative and nad(p)h oxidase inhibitor containing the same
08/31/2005CN1662524A Indole derivatives useful as histamine h3 antagonists
08/31/2005CN1662522A Novel compounds, their use and preparation
08/31/2005CN1662506A Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
08/31/2005CN1662498A Novel tetrahydropyridine derivatives as renin inhibitors
08/31/2005CN1662496A Cannabinoid receptor agonists
08/31/2005CN1662490A Nitrooxyderivatives of cyclooxygenase-2 inhibitors
08/31/2005CN1662242A Pharmaceutical compositions for the treatment of diseases related to neurotrophines
08/31/2005CN1662236A Inhibitors of histone deacetylase
08/31/2005CN1660911A Connective tissue growth factor fragments and methods and uses thereof
08/31/2005CN1660840A Phthalazine derivatives for treating inflammatory diseases
08/31/2005CN1660839A Chemical compounds
08/31/2005CN1660388A Oral Chinese material medica preparation for regulating blood sugar and improving immunologic function and preparation method
08/31/2005CN1660386A Health care wine and preparation method
08/31/2005CN1660349A Combination of medication by using beartyberry and dragon's blood resin as combination of activities
08/31/2005CN1660312A Recipe for treating secretory otitis media also allergic rhinitis and preparation method
08/31/2005CN1660267A 'Yankening' pharmaceutical preparation and preparing method
08/31/2005CN1660226A 'Wuzi Mingmu' pill and preparing technique
08/31/2005CN1660132A Combination for local use for preventing anti treating ocular disease
08/31/2005CN1660095A Oral liquid of compound anisodine, preparation method and usage
08/31/2005CN1660063A Application of aspartic acid and its salt
08/31/2005CN1660060A Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia
08/31/2005CN1217190C Modulation of smrl-nep interactions in cns disorders giving rise to mental disorders
08/31/2005CN1216873C Valsartan salts
08/31/2005CN1216869C Polymorphic crystalline forms of celecoxib
08/31/2005CN1216867C 2-amino-nicotinamide derivative sand their use as VEGF-receptor tyrosine kinase inhibitors
08/31/2005CN1216866C Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
08/31/2005CN1216857C Aniline-derived ligands for thyroid receptor
08/31/2005CN1216636C Titanium slow-release composition
08/31/2005CN1216602C Combination of lipoic acids and conjugated acids for treating diabetic disorders
08/30/2005US6936715 Lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
08/30/2005US6936691 Secreted protein HCE3C63
08/30/2005US6936633 Pyrrolidinone derivatives
08/30/2005US6936627 treating/preventing gastrointestinal disorders, inflammations and microbial infections; improving gastroprotective properties of H2 receptor antagonists; decreasing the recurrence of ulcers; facilitating ulcer healing
1 ... 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 ... 531